I
Illumina ILMN
$207.01
−1.21%
Nov 13
1W
1M
3M
6M
1Y
3Y
5Y
Activities
Key indicators
Sales
+6%
$4.54B over 12 months
Net margin
20%
Low
High
Volatility
48%
Calm
Choppy
Bars: against the 7 close companies.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
Earnings release
The day the company publishes its quarterly accounts: revenue, profit, and often its outlook. The price sometimes moves sharply that day, in either direction. Over the long term, what matters is the trend of profits from one quarter to the next, not the reaction of the day.
Posts
No posts about ILMN yet.
About Illumina, Inc. Common Stock
Illumina makes DNA sequencing machines and the chemicals and software used to run them. It sells instruments to labs, hospitals and drug makers, and earns most of its revenue from repeat sales of consumables and services tied to those machines. Its customers use the technology in cancer testing, reproductive health and research.